Geriatrics News

Eli Lilly recently announced that solanezumab did not achieve a statistically significant reduction in cognitive decline among individuals with mild dementia due to Alzheimer’s disease.

Individuals with Alzheimer’s disease had significantly higher salivary A42 levels, compared with peers who did not have the disorder, suggesting utility of A42 levels to diagnose and predict future risk for Alzheimer’s disease.

Patients with Alzheimer’s disease who received 2 years of home-based occupational therapy did not show improvements in functionality, according to research published in Annals of Internal Medicine.

Recent findings indicated computerized cognitive training improved cognition in older adults with mild cognitive impairment or dementia.

Between 2000 and 2012, there a significant reduction in the number of individuals living with dementia in the United States, according to findings published in JAMA Internal Medicine.

The Alzheimer’s Association recently awarded a 2016 research grant to Claudia Satizabal, PhD, of Boston University School of Medicine, to study how obesity affects brain aging and Alzheimer’s disease.

The National Institute on Aging recently awarded a 5-year, $21.8 million grant to Kirk Erickson, PhD, of the University of Pittsburgh, to study associations between exercise and brain health in older adults.

The National Institute on Aging recently awarded a $10.3 million 5-year program project grant to Roberta Diaz Brinton, PhD, of the University of Arizona Health Sciences, and her colleagues to assess why women develop Alzheimer’s disease more often than men.

Cognitively normal older adults with higher cortical amyloid burden or apolipoprotein E 4 were more likely to report loneliness, suggesting it may be a neuropsychiatric symptom of preclinical Alzheimer’s disease.

Many elderly adults are not engaging in advance care planning, which includes discussing care and designating a power of attorney, according to findings published in JAMA Internal Medicine.